We observed that both AD and MCI patients had significantly lower CSF Aβ1-42, increased CSF total and phosphorylated tau, lower CSF ApoE, and higher frequency of the APOE ε4 genotype, all of which have been reported and were positive controls for the experiment. The gene discussed is APOE; the disease is Alzheimer disease.